Deciphex provides digital pathology solutions that leverage AI to enhance pathology service delivery and improve diagnostic turnaround times.

Deciphex

Deciphex is focused on the development of software applications for preclinical/toxicologic pathology that improve productivity and help pathologists focus on the critical content.

The pathology industry is beset with increasing caseload and diagnostic complexity, against a globally declining number of pathologists to service the workload.

We believe that digital pathology combined with computer aided diagnostic tools will help make pathologists work more efficiently in the future, and offers a solution to the pending crisis in supply/demand in pathology services.



Claret Capital Partners

Act Venture Capital

GI Partners

Irrus Investments

Enterprise Ireland

NextSteps Capital

Seroba Life Sciences

Halo Business Angel Network

HBAN Medtech Syndicate

Charles River Laboratories International

Novartis

Inova Personalized Health Accelerator

The Patholytix Data Capture Module is a game-changer for non-clinical study reviews, enabling users to review and score studies on a single platform for the first time. Its dynamic workflows for glass, digital, and hybrid studies, real-time data sync capabilities, geolocated findings, and flexible scoring templates accelerate critical decisions in drug safety assessment.

Watch our webinar on-demand to find out more:  https://lnkd.in/eX7bnUUY

#digitalpathology #drugdiscovery #pathologyreviews #datamanagement #drugdevelopment #GLP #nonGLP #datacapture #Webinar #PatholytixDCM

Congratulations to the entire Deciphex team on our double win at the Irish Medtech Awards! 🎉 We're absolutely thrilled to have been named Medtech Company of the Year and to receive the Digital Health Innovation of the Year award. 🏆🏆

This recognition means the world to us and is a testament to the hard work, dedication, and innovation that drives us every day. Thank you to the Irish Medtech Association, IDA Ireland, Enterprise Ireland, and everyone who has supported us on this incredible journey.

We couldn't have achieved this without our amazing team and partners. Here's to pushing the boundaries of medtech and digital health! 🚀 

#MedtechRising #IrishMedtechAwards


A few weeks ago, our research paper, "Synergies and Challenges in the Preclinical and Clinical Implementation of Pathology Artificial Intelligence Applications", was published. Are you curious about the key takeaways? Watch Max Qureshi share insights below in this ‘Authors Insights’ video from the Mayo Clinic!

📄 Access the full paper: https://lnkd.in/g5kQ5WjU

Discover the future of pathology with us! 🌟 #PathologyAI #Research #Innovation

📢 We are thrilled to announce the recent publication of a paper authored by our Chief Medical Officer, Prof. Runjan Chetty, and Senior Manager for Technical Integration & Support, James Johnson, on the implementation of digital pathology workflows.

In today's rapidly evolving healthcare landscape, digital pathology is proving to be a transformative technology. The paper presents a comprehensive management approach to successfully navigate the challenges associated with its implementation.

Key highlights from the paper include the importance of stakeholder engagement from hospital administration, IT, and laboratory management, as well as the necessity of developing a customised business case tailored to local needs. It emphasises the need to assess the impact of this "disruptive" technology on work habits and workflow and recommends planning for the selection of scanners and software that seamlessly integrate with the laboratory information system.

Additionally, the authors stress the criticality of service contracts and redundancy planning to mitigate potential disruptions due to scanner failure or breakdown. The paper also outlines a phased approach to pathologist management, including formal validation and ongoing monitoring.

We extend our warm congratulations to Prof. Runjan Chetty and James Johnson for their exceptional work on this paper. 🌟

This paper is essential reading for healthcare professionals considering the adoption of digital pathology. It offers practical insights to ensure a smooth transition into this innovative technology.

Access the full paper here: https://lnkd.in/eae3Zzbm

#DigitalPathology #HealthcareInnovation #MedicalTechnology #HealthTech


IPhone / Mobile Compatible

Viewport Meta

Domain Not Resolving

SSL by Default

Euro

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

Google Analytics

Chief Operations Officer (COO)

Mairin Rafferty

Senior Director of Enterprise Architecture and Core Technologies

Andrea Rizzini

Quality

Brian Mulcahy

Director of Human Resources

Ciara Mullin

Finance and Administration

Derek Small

Engineering

Mark Gregson

General Manager, Preclinical Pathology

Shane Ryan

Sales & Product Application Specialist

Andrew Fink

Research Projects Manager

Caitriona Lyons

Clinical Laboratory Manager US

Erin Lucas

Jennifer McMahon

Donal O'Shea

Act Venture Capital Portfolio Companies

Biotechnology Early Stage Companies With Fewer Than 1000 Employees

HBAN Portfolio Companies

Health Diagnostics Female Founded Companies with Early Stage Venture Funding

Deciphex is an Irish-based software company focused on developing digital pathology-based solutions for clinical and research pathology. Our ambition is to deliver solutions that provide tangible productivity benefits to pathologists, eliminating low-level tasks so they can focus on the critical content. We believe that digital pathology combined with artificial intelligence will help make pathologists work more efficiently in the future, offering a solution to the pending challenges in supply/demand in pathology services. Deciphex plans to be at the forefront of this revolution with cleverly positioned solutions that deliver on the biggest problems facing pathology today.

Debt Financing - Deciphex

Series B - Deciphex

Series A - Deciphex

Venture Round - Deciphex

Seed Round - Deciphex

Computer and Software Products and Electrical and Scientific Products

Dublin

Ireland

Europe

Deciphex partners with Novartis for AI drug research

Irish medtech scores €15m AI partnership with Novartis

Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for ...

Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology

Deciphex crowned Irish medtech company of the year

A digital pathology platform designed to enhance the efficiency of pathology workflows through AI and web-based access.

A service offering remote diagnostic consultations and pathology expertise, leveraging a network of pathologists.

An AI-powered decision support tool for toxicologic pathology, developed in collaboration with Charles River Laboratories.

Provides analytics services by developing, validating, and running AI models on whole slide images for various complexities.

Switzerland

Brazil

South America

India

Asia

Austria

Pakistan

HTML5

Adobe Fonts

Amazon Route 53

Google Maps API

jQuery

Google Fonts

PathAI is a company that specializes in developing artificial intelligence solutions for pathology and laboratory medicine.

PathAI

Proscia is a digital pathology company that provides software solutions for transforming pathology labs with modern technology.

Proscia

IBEX is a company specializing in AI-powered cancer detection and diagnostics for pathology and radiology.

IBEX

Quantum Computing is a company focused on developing quantum computing technologies for various applications.

Quantum Computing

MOBILion Systems Inc specializes in high-resolution ion mobility mass spectrometry for applications in life sciences and related fields.

MOBILion Systems Inc

Deciphex is a technology company specializing in digital pathology and AI solutions for the healthcare industry.

news impact assignment basic	general	Feb 16, 2024 1:54 AM	3dfa47f9
public peers	general	Oct 2, 2024 2:59 PM	a8f9f3b8
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Oct 8, 2024 4:30 PM	5a862e0e
company summary	general
signals	general	Oct 2, 2024 2:59 PM	fb7f083b
crunchbase trigger	general	Nov 27, 2024 12:50 PM	46de91eb
crunchbase profile	general	Nov 28, 2024 8:59 AM	14ef6146
li profile	general	Feb 16, 2024 1:54 AM	d3500da2
translate crunchbase fundingrounds	general	Nov 28, 2024 10:18 AM	f85c63ef
peers	general	Oct 2, 2024 2:59 PM	20d68940
news basic	general	Oct 2, 2024 2:59 PM	759fc8c7
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:DECIPHEX

Deciphex